false 0001450704 0001450704 2025-10-30 2025-10-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 30, 2025

VIVAKOR, INC.

(Exact name of registrant as specified in its charter)

Nevada |  | 001-41286 |  | 26-2178141
(State or other jurisdiction of |  | (Commission |  | (IRS Employer
incorporation or organization) |  | File Number) |  | Identification No.)

5220 Spring Valley Road, Suite 500

Dallas, TX 75254

(Address of principal executive offices)

(469) 480-7175

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None

Title of each class |  | Trading Symbol(s) |  | Name of each exchange on which registered
Common Stock |  | VIVK |  | The Nasdaq Stock Market LLC (Nasdaq Capital Market)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

ITEM 7.01 | Regulation FD Disclosure.

On October 30, 2025, Vivakor, Inc. (“Vivakor” or the “Company”) issued a press release announcing initiation of a commodity trade transaction utilizing Vivakor Supply & Trading, LLC, a wholly-owned subsidiary of Vivakor. The full text of the press release is attached to this Current Report on Form 8-K (this “Report”) as Exhibit 99.1 and is incorporated herein by reference in this Item 7.01.

Effective October 30, 2025, senior management and other representatives of Vivakor began using the investor presentation (the “Investor Presentation”) included as Exhibit 99.2 to this Report in connection with presentations to existing shareholders of the Company, potential investors of the Company, and the investment community.

Without limiting the generality of the foregoing, the “Forward-Looking Statements” disclosure contained in the Investor Presentation is incorporated by reference into this Item 7.01. A copy of the press release and the Investor Presentation are furnished as Exhibits 99.1 and 99.2 of this Report, respectively. The information contained in this Report, including Exhibits 99.1 and 99.2 furnished herewith, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

1

ITEM 9.01 | Financial Statements and Exhibits.

(d) | Exhibits

Exhibit No. |  | Title
99.1 |  | Press Release dated October 30, 2025 regarding Vivakor Supply & Trading Commodity Transaction
99.2 |  | Investor Presentation
104 |  | Cover Page Inte ractive Data File (formatted as Inline XBRL).

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| VIVAKOR, INC.
Dated: October 30, 2025 | By: | /s/ James H. Ballengee
|  | Name: | James H. Ballengee
|  | Title: | Chairman, President & CEO

3